Menu
Search
|

Menu

Close
X

IRIDEX Corp IRIX.OQ (NASDAQ Stock Exchange Global Market)

7.30 USD
+0.39 (+5.64%)
As of 1:30 AM IST
chart
Previous Close 6.91
Open 6.97
Volume 11,741
3m Avg Volume 3,921
Today’s High 7.66
Today’s Low 6.97
52 Week High 10.35
52 Week Low 4.78
Shares Outstanding (mil) 11.57
Market Capitalization (mil) 114.98
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
10
FY17
42
FY16
46
FY15
42
EPS (USD)
FY18
-0.310
FY17
-1.113
FY16
-1.124
FY15
0.047
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
2.69
5.73
Price to Book (MRQ)
vs sector
3.06
5.47
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
0.00
16.84
LT Debt to Equity (MRQ)
vs sector
0.00
12.51
Return on Investment (TTM)
vs sector
-44.05
14.61
Return on Equity (TTM)
vs sector
-44.66
16.34

EXECUTIVE LEADERSHIP

William Moore
Chairman of the Board, Interim President and Chief Executive Officer, Since 2012
Salary: $501,347.00
Bonus: --
Atabak Mokari
Chief Financial Officer, Vice President - Corporate Development, Since 2016
Salary: $336,132.00
Bonus: --
David Bruce
Director, Since 2018
Salary: --
Bonus: --
Ann Rhoads
Director, Since 2017
Salary: --
Bonus: --
Maria Sainz
Director, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

1212 Terra Bella Ave
MOUNTAIN VIEW   CA   94043-1824

Phone: +1650.9404700

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

SPONSORED STORIES